<?xml version="1.0" encoding="UTF-8" ?>

<Genomics_ConceptTask>
<TEXT><![CDATA[Mitophagy regulates mitochondrial network signaling, oxidative stress, and 
apoptosis during myoblast differentiation.

Macroautophagy/autophagy is a degradative process essential for various cellular 
processes. We previously demonstrated that autophagy-deficiency causes myoblast 
apoptosis and impairs myotube formation. In this study, we continued this work 
with particular emphasis on mitochondrial remodelling and stress/apoptotic 
signaling. We found increased (p < 0.05) autophagic (e.g., altered LC3B levels, 
increased ATG7, decreased SQSTM1) and mitophagic (e.g., BNIP3 upregulation, 
mitochondrial localized GFP-LC3 puncta, and elevated mitochondrial LC3B-II) 
signaling during myoblast differentiation. shRNA-mediated knockdown of ATG7 
(shAtg7) decreased these autophagic and mitophagic responses, while increasing 
CASP3 activity and ANXA5/annexin V staining in differentiating myoblasts; 
ultimately resulting in dramatically impaired myogenesis. Further confirming the 
importance of mitophagy in these responses, CRISPR-Cas9-mediated knockout of 
Bnip3 (bnip3-/-) resulted in increased CASP3 activity and DNA fragmentation as 
well as impaired myoblast differentiation. In addition, shAtg7 myoblasts 
displayed greater endoplasmic reticulum (e.g., increased CAPN activity and HSPA) 
and mitochondrial (e.g., mPTP formation, reduced mitochondrial membrane 
potential, elevated mitochondrial 4-HNE) stress. shAtg7 and bnip3-/- myoblasts 
also displayed altered mitochondria-associated signaling (e.g., PPARGC1A, DNM1L, 
OPA1) and protein content (e.g., SLC25A4, VDAC1, CYCS). Moreover, shAtg7 
myoblasts displayed CYCS and AIFM1 release from mitochondria, and CASP9 
activation. Similarly, bnip3-/- myoblasts had significantly higher CASP9 
activation during differentiation. Importantly, administration of a chemical 
inhibitor of CASP9 (Ac-LEHD-CHO) or dominant-negative CASP9 (ad-DNCASP9) 
partially recovered differentiation and myogenesis in shAtg7 myoblasts. 
Together, these data demonstrate an essential role for autophagy in protecting 
myoblasts from mitochondrial oxidative stress and apoptotic signaling during 
differentiation, as well as in the regulation of mitochondrial network 
remodelling and myogenesis.]]></TEXT>
<TAGS>
<PERTURBING_ACTION id="P1" spans="717~759" text="shRNA-mediated knockdown of ATG7  (shAtg7)" perturbingaction="rnai/knockdown" />
<PERTURBING_ACTION id="P2" spans="1032~1082" text="CRISPR-Cas9-mediated knockout of  Bnip3 (bnip3-/-)" perturbingaction="gene loss-of-function" />
<PERTURBING_ACTION id="P3" spans="1202~1208" text="shAtg7" perturbingaction="rnai/knockdown" />
<PERTURBING_ACTION id="P4" spans="1424~1430" text="shAtg7" perturbingaction="rnai/knockdown" />
<PERTURBING_ACTION id="P5" spans="1435~1443" text="bnip3-/-" perturbingaction="gene loss-of-function" />
<PERTURBING_ACTION id="P6" spans="1603~1609" text="shAtg7" perturbingaction="rnai/knockdown" />
<PERTURBING_ACTION id="P7" spans="1707~1715" text="bnip3-/-" perturbingaction="gene loss-of-function" />
<PERTURBING_ACTION id="P9" spans="1872~1908" text="dominant-negative CASP9 (ad-DNCASP9)" perturbingaction="gene loss-of-function" />
<PERTURBING_ACTION id="P10" spans="1964~1970" text="shAtg7" perturbingaction="rnai/knockdown" />
<PERTURBING_ACTION id="P11" spans="1826~1868" text="chemical  inhibitor of CASP9 (Ac-LEHD-CHO)" perturbingaction="pharmacological inhibition" />
<CONTEXT id="C0" spans="878~903" text="differentiating myoblasts" context="cells" />
<CONTEXT id="C1" spans="1163~1171" text="myoblast" context="cells" />
<CONTEXT id="C2" spans="1209~1218" text="myoblasts" context="cells" />
<CONTEXT id="C3" spans="1444~1453" text="myoblasts" context="cells" />
<CONTEXT id="C4" spans="1611~1620" text="myoblasts" context="cells" />
<CONTEXT id="C5" spans="1716~1725" text="myoblasts" context="cells" />
<CONTEXT id="C6" spans="1971~1980" text="myoblasts" context="cells" />
<PHENOTYPE id="PH0" spans="1172~1187" text="differentiation" phenotype="differentiation" />
<PHENOTYPE id="PH1" spans="1930~1945" text="differentiation" phenotype="differentiation" />
<EFFECT id="E0" spans="1154~1162" text="impaired" effect="negative" />
<EFFECT id="E1" spans="1920~1929" text="recovered" effect="rescues" />
<ENTITY_LINKING id="EN0" perturbing_actionID="P2" perturbing_actionText="CRISPR-Cas9-mediated knockout of  Bnip3 (bnip3-/-)" contextID="C1" contextText="myoblast" phenotypeID="PH0" phenotypeText="differentiation" effectID="E0" effectText="impaired" />
<ENTITY_LINKING id="EN1" perturbing_actionID="P11" perturbing_actionText="chemical  inhibitor of CASP9 (Ac-LEHD-CHO)" contextID="C6" contextText="myoblasts" phenotypeID="PH1" phenotypeText="differentiation" effectID="E1" effectText="recovered" />
<ENTITY_LINKING id="EN2" perturbing_actionID="P9" perturbing_actionText="dominant-negative CASP9 (ad-DNCASP9)" contextID="C6" contextText="myoblasts" phenotypeID="PH1" phenotypeText="differentiation" effectID="E1" effectText="recovered" />
</TAGS>
</Genomics_ConceptTask>